Metallic nanoparticles as drug delivery system for the treatment of cancer

被引:103
作者
Desai, Neha [1 ]
Momin, Munira [1 ]
Khan, Tabassum [2 ]
Gharat, Sankalp [1 ]
Ningthoujam, Raghumani Singh [3 ]
Omri, Abdelwahab [4 ]
机构
[1] Univ Mumbai, SVKMs Dr Bhanuben Nanavati Coll Pharm, Dept Pharmaceut, Mumbai, Maharashtra, India
[2] Univ Mumbai, SVKMs Dr Bhanuben Nanavati Coll Pharm, Dept Pharmaceut Chem & Qual Assurance, Mumbai, Maharashtra, India
[3] Bhabha Atom Res Ctr, Chem Div, Trombay, India
[4] Laurentian Univ, Dept Chem & Biochem, Novel Drug & Vaccine Delivery Syst Facil, 935 Ramsey Lake Rd, Sudbury, ON P3E 2C6, Canada
关键词
Gold nanoparticle; malignant tumor; metallic nanoparticle; nanocarrier; silver nanoparticle; theranostic; SURFACE-PLASMON RESONANCE; HOLLOW GOLD NANOPARTICLES; IN-VIVO; SILVER NANOPARTICLES; PARTICLE-SIZE; BREAST-CANCER; INTRAVENOUS-INJECTION; PHOTOTHERMAL ABLATION; TISSUE DISTRIBUTION; CONTRAST AGENTS;
D O I
10.1080/17425247.2021.1912008
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction The targeted delivery of anticancer agents to tumor is a major challenge because most of the drugs show off-target effect resulting in nonspecific cell death. Multifunctionalized metallic nanoparticles (NPs) are explored as new carrier system in the era of cancer therapeutics. Researchers investigated the potential of metallic NPs to target tumor cells by active and passive mechanisms, thereby reducing off-target effects of anticancer agents. Moreover, photocatalytic activity of upconversion nanoparticles (UCNPs) and the enhanced permeation and retention (EPR) effect have also gained wide potential in cancer treatment. Recent advancement in the field of nanotechnology highlights their potency for cancer therapy. Areas covered This review summarizes the types of gold and silver metallic NPs with targeting mechanisms and their potentiality in cancer therapy. Expert opinion Recent advances in the field of nanotechnology for cancer therapy offer high specificity and targeting efficiency. Targeting tumor cells through mechanistic pathways using metallic NPs for the disruption/alteration of molecular profile and survival rate of the tumor cells has led to an effective approach for cancer therapeutics. This alteration in the survival rate of the tumor cells might decrease the proliferation thereby resulting in more efficient management in the treatment of cancer.
引用
收藏
页码:1261 / 1290
页数:30
相关论文
共 333 条
[41]   Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity [J].
Boisselier, Elodie ;
Astruc, Didier .
CHEMICAL SOCIETY REVIEWS, 2009, 38 (06) :1759-1782
[42]   NBTXR3, a first-in-class radioenhancer hafnium oxide nanoparticle, plus radiotherapy versus radiotherapy alone in patients with locally advanced soft-tissue sarcoma (Act. In. Sarc): a multicentre, phase 2-3, randomised, controlled trial [J].
Bonvalot, Sylvie ;
Rutkowski, Piotr L. ;
Thariat, Juliette ;
Carrere, Sebastien ;
Ducassou, Anne ;
Sunyach, Marie-Pierre ;
Agoston, Peter ;
Hong, Angela ;
Mervoyer, Augustin ;
Rastrelli, Marco ;
Moreno, Victor ;
Li, Rub K. ;
Tiangco, Beatrice ;
Herraez, Antonio Casado ;
Gronchi, Alessandro ;
Mangel, Laszlo ;
Sy-Ortin, Teresa ;
Hohenberger, Peter ;
de Baere, Thierry ;
Le Cesne, Axel ;
Helfre, Sylvie ;
Saada-Bouzid, Esma ;
Borkowska, Aneta ;
Anghel, Rodica ;
Co, Ann ;
Gebhart, Michael ;
Kantor, Guy ;
Montero, Angel ;
Loong, Herbert H. ;
Verges, Ramona ;
Lapeire, Lore ;
Dema, Sorin ;
Kacso, Gabriel ;
Austen, Lyn ;
Moureau-Zabotto, Laurence ;
Servois, Vincent ;
Wardelmann, Eva ;
Terrier, Philippe ;
Lazar, Alexander J. ;
Bovee, Judith V. M. G. ;
Le Pechoux, Cecile ;
Papi, Zsusanna .
LANCET ONCOLOGY, 2019, 20 (08) :1148-1159
[43]   Gold Nanoparticles for the Improved Anticancer Drug Delivery of the Active Component of Oxaliplatin [J].
Brown, Sarah D. ;
Nativo, Paola ;
Smith, Jo-Ann ;
Stirling, David ;
Edwards, Paul R. ;
Venugopal, Balaji ;
Flint, David J. ;
Plumb, Jane A. ;
Graham, Duncan ;
Wheate, Nial J. .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2010, 132 (13) :4678-4684
[44]   SYNTHESIS OF THIOL-DERIVATIZED GOLD NANOPARTICLES IN A 2-PHASE LIQUID-LIQUID SYSTEM [J].
BRUST, M ;
WALKER, M ;
BETHELL, D ;
SCHIFFRIN, DJ ;
WHYMAN, R .
JOURNAL OF THE CHEMICAL SOCIETY-CHEMICAL COMMUNICATIONS, 1994, (07) :801-802
[45]   SPECIFIC MR IMAGING OF HUMAN-LYMPHOCYTES BY MONOCLONAL ANTIBODY-GUIDED DEXTRAN-MAGNETITE PARTICLES [J].
BULTE, JWM ;
HOEKSTRA, Y ;
KAMMAN, RL ;
MAGIN, RL ;
WEBB, AG ;
BRIGGS, RW ;
GO, KG ;
HULSTAERT, CE ;
MILTENYI, S ;
THE, TH ;
DELEIJ, L .
MAGNETIC RESONANCE IN MEDICINE, 1992, 25 (01) :148-157
[46]   Active targeting schemes for nanoparticle systems in cancer therapeutics [J].
Byrne, James D. ;
Betancourt, Tania ;
Brannon-Peppas, Lisa .
ADVANCED DRUG DELIVERY REVIEWS, 2008, 60 (15) :1615-1626
[47]  
Caban S., 2014, OA Drug Design and Delivery, V2, P1
[48]   Applications of gold nanoparticles in cancer nanotechnology [J].
Cai, Weibo ;
Gao, Ting ;
Hong, Hao ;
Sun, Jiangtao .
NANOTECHNOLOGY SCIENCE AND APPLICATIONS, 2008, 1 :17-32
[49]  
Capjak I., 2016, BEILSTEIN J NANOTECH, V7, P141
[50]   Microenvironment regulates the expression of miR-21 and tumor suppressor genes PTEN, PIAS3 and PDCD4 through ZAP-70 in chronic lymphocytic leukemia [J].
Carabia, Julia ;
Carpio, Cecilia ;
Abrisqueta, Pau ;
Jimenez, Isabel ;
Purroy, Noelia ;
Calpe, Eva ;
Palacio, Carles ;
Bosch, Francesc ;
Crespo, Marta .
SCIENTIFIC REPORTS, 2017, 7